Clinical Trials Directory

Trials / Completed

CompletedNCT02983305

Optical Head-Mounted Display Technology for Low Vision Rehabilitation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to examine the ability of optical head-mounted display technology to enlarge the visual field of patients with severe visual field loss due to retinal dystrophy and to improve mobility and patient-reported outcomes.

Detailed description

Worldwide it is estimated that 191 million people have moderate to severe visual impairment (MSVI) and an additional 32.4 million are blind. Patients with uncorrectable MSVI may undergo low vision rehabilitation (LVR), which has been shown to improve functional abilities, such as mobility. However, existing LVR strategies do not adequately address severe visual field constriction. In this pilot study, the investigators will test the hypothesis that optical head-mounted display (HMD) technology expands constricted visual fields and improves mobility outcomes for patients with retinal dystrophy. We will use the Moverio HMD platform which is considered a non-significant risk device. Outcomes for patients with retinal dystrophy will be compared to normal age-matched controls.

Conditions

Interventions

TypeNameDescription
DEVICEHead-Mounted DisplayHead-mounted displays (HMD) are a class of technology that are worn on the user's head and project an image either in front of or into the eye.

Timeline

Start date
2017-06-26
Primary completion
2018-11-21
Completion
2018-11-21
First posted
2016-12-06
Last updated
2019-10-09
Results posted
2019-10-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02983305. Inclusion in this directory is not an endorsement.